Different forms of vanadate on sugar transport in insulin target and nontarget cells

Journal of Biomedicine and Biotechnology

Volumn 2002, Issue 1, 2002, Pages 22-30

  Germinario, Ralph J ^a,c   Colby Germinario, Susan P ^a   Posner, Barry I ^a,c   Nahm, K ^b  

^a MCGILL UNIVERSITY   (Canada)

^b Civil and Environmental Engineering   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORTHOVANADIC ACID; PEROXOVANADIC ACID DERIVATIVE; PERVANADATE; UNCLASSIFIED DRUG; VANADIC ACID;

ADIPOCYTE; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MUSCLE FIBRIL; STIMULUS RESPONSE; SUGAR TRANSPORT; TARGET CELL;

EID: 28544444585     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/S1110724302000402     Document Type: Article

References (41)

1. Underwood EJ. Trace Elements in Human and Animal Nutrition. 4th ed. New York, NY: Academic Press; 1977.
2. Golden MH, Golden BE. Trace elements, potential importance in human nutrition with particular reference to zinc and vanadium. Br Med Bull. 1981;37:31-36.
3. Tolman EL, Barris E, Burns M, Pansini A, Partridge R. Effects of vanadium on glucose metabolism in vitro. Life Sci. 1979;25:1159-1164.
4. Clark AS, Fagan JM, Mitch WE. Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem J. 1985;232:273-276.
5. 2. J Biol Chem. 1987;262:8252-8256.
6. Tsiani E, Bogdanovic E, Sorisky A, Nagy L, Fantus IG. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes. 1998;47:1676-1686.
7. Brichard SM, Okitolonda W, Henquin JC. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology. 1988;123:2048-2053.
8. Blondel O, Bailbe D, Portha B. In vivo insulin resistance in streptozotocin-diabetic rats-evidence for reversal following oral vanadate treatment. Diabetologia. 1989;32:185-190.
9. Cantley LC, Josephson L, Warner R, Yanagisawa M, Lechene C, Guidotti G. Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem. 1977;252:7421-7423.
10. Swarup G, Cohen S, Garbers DL. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun. 1982;107:1104-1109.
11. Swarup G, Speeg KV Jr, Cohen S, Garbers DL. Phosphotyrosyl-protein phosphatase of TCRC-2 cells, J Biol Chem. 1982;257:7298-7301.
12. Sekar N, Li J, Shechter Y. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol. 1996;31:339-359.
13. Tsiani E, Fantus IG. Vanadium compounds: biological actions and potential as pharmacological agents. Trends Endocrinol Metab. 1997;8:51-58.
14. Heyliger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science. 1985;227:1474-1477.
15. Meyerovitch J, Farfel Z, Sack J, Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem. 1987;262:6658-6662.
16. Fantus IG, Kadota S, Deragon G, Foster B, Posner BI. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry. 1989;28:8864-8871.
17. Posner BI, Faure R, Burgess JW, et al. Peroxovanadium compounds: a new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem. 1994;269:4596-4604.
18. Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem. 1994;269:29934-29942.
19. Frost SC, Lane MD. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985;260:2646-2652.
20. Germinario RJ, Oliveira M, Leung H. Saturable and nonsaturable hexose uptake in cultured human skin fibroblasts. Can J Biochem. 1978;56:80-88.
21. Germinario RJ, McQuillan A, Oliveira M, Manuel S. Enhanced insulin stimulation of sugar transport and DNA synthesis by glucocorticoids in cultured human skin fibroblasts. Arch Biochem Biophys. 1983;226:498-505.
22. Lowry OH, Roseborough NJ, Farr NJ, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem. 1955;193:265-275.
23. Germinario RJ, Lakshmi TM, Thirion JP. Kinetic characteristics and regulation of hexose transport in a galactokinase-negative Chinese hamster fibroblast cell line: a good model for studies on sugar transport in cultured mammalian cells. J Cell Physiol. 1989;138:300-304.
24. Pratt SE, Colby-Germinario SP, Manuel S, Germinario RJ. Evidence that modulation of glucose transporter intrinsic activity is the mechanism involved in the allose-mediated depression of hexose transport in mammalian cells. J Cell Physiol. 1994;161:580-588.
25. Tao Y, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. Acylation stimulating protein (ASP) regulates sugar transport in the rat L6 muscle cell line. Biochem Biophys Acta. 1997;1344:221-229.
26. Germinario RJ, Manuel S, Chang Z, Leckett B. Inhibitors of protein synthesis cause increased hexose transport in cultured human fibroblasts by a mechanism other than transporter translocation. J Cell Physiol. 1992;151:156-163.
27. Baldwin SA, Baldwin JM, Lienhard GE. Monosaccharide transporter of the human erythrocyte. Characterization of an improved preparation. Biochemistry. 1982;21:3836-3842.
28. Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI. Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun. 1987;147:259-266.
29. Gould GW, Derechin V, James DE, et al. Insulin-stimulated translocation of the HepG2/erythrocyte-type glucose transporter expressed in 3T3-L1 adipocytes. J Biol Chem. 1989;264:2180-2184.
30. Thurmond DC, Ceresa BP, Okada S, Elmendorf JS, Coker K, Pessin JE. Regulation of insulin-stimulated GLUT4 translocation by Munc18c in 3T3 L1 adipocytes. J Biol Chem. 1998;273:33876-33883.
31. Charron MJ, Katz EB, Olson AL. GLUT4 gene regulation and manipulation. J Biol Chem. 1999;274:3253-3256.
32. Roshchin AV, Ordzhonikidze EK, Shalganova IV. Vanadium-toxicity, metabolism, carrier state. J Hyg Epidemiol Microbiol Immunol. 1980;24:377-383.
33. Domingo JL, Llobet JM, Tomas JM, Corbella J. Short term toxicity study of vanadium in rats. J Appl Toxicol. 1985;B5:418-421.
34. Llobet JM,-Domingo JL. Acute toxicity of vanadium compounds in rats and mice. Toxicol Lett. 1984;23:227-231.
35. Gil J, Miralpeix M, Carreras J, Bartrons R. Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem. 1988;263:1868-1871.
36. Tsiani E, Abdullah N, Fantus IG. Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake. Am J Physiol. 1997;272:C156-C162.
37. Ewart HS, Klip A. Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995;269:C295-C311.
38. Foot E, Bliss T, Fernandes LC, Da Costa C, Leighton B. The effects of orthovanadate, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparations in vitro. Mol Cell Biochem. 1992;109:157-162.
39. Shisheva A, Shechter Y. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Endocrinology. 1993;133:1562-1568.
40. Huyer G, Liu S, Kelly J, et al. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. 1997;272:843-851.
41. Elberg G, Li J, Leibovitch A, Shechter Y. Non-receptor cytosolic protein tyrosine kinases from various rat tissues. Biochim Biophys Acta. 1995;1269:299-306.